Morristown-based Sanofi will be the latest U.S drugmaker to inject billions of dollars into domestic operations and American ...

Emrelis is the first FDA-approved treatment for previously treated patients with locally advanced or metastatic non-squamous ...

We finally have a schedule for the New England Patriots 2025 season. Dan Roche discusses his thoughts on the upcoming season with Joe Weil.

The antibody-drug conjugate is approved for previously treated advanced NSCLC patients with high c-Met protein overexpression ...

I knew it was bound to happen at some point, but this soon – if you’re thinking in context, 10 years is not that far off. So, ...

Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

Roche is among several drugmakers to announce large-scale U.S. investments in response to Trump's push to onshore ...

The test detects the MET protein that is over-expressed in some patients with non-squamous non-small cell lung cancer.

While M&A activity slowed in the first quarter of 2025, including in life sciences, there have been plenty of noteworthy developments in the ...

A new promo for Roche’s blockbuster hemophilia A drug Hemlibra focuses less on those with the genetic bleeding disorder and ...

U.S. President Donald Trump's executive order on drug pricing threatens Roche's planned $50 billion investment in the United ...

President Donald Trump's executive order on drug pricing may threaten Roche's planned $50 billion investment in the U.S. By ...